Publication Date:
2019
abstract:
The ideal treatment for GD would be to target its pathogenic mechanisms by modulating the autoimmune process directed against the TSH receptor or by competing with thyroid-stimulating antibody. While waiting for novel
therapeutic tools, the management of GD in its different grades of severity and complications still requires a careful
clinical approach and biochemical evaluation aimed at an early discrimination between eventually relapsing and
remitting patients after medical therapy. Last, but not least, all available treatment options and their outcomes should be discussed with the patient. This decision process will, in many ways, provide personalized treatment utilizing the best therapeutic tools currently available.
Iris type:
1.1 Articolo in rivista
Keywords:
graves disease, precision medicine, medical therapy
List of contributors:
Chiovato, Luca; Magri, Flavia
Published in: